These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36243981)
1. A functional SNP regulates E-cadherin expression by dynamically remodeling the 3D structure of a promoter-associated non-coding RNA transcript. Sharma S; Pisignano G; Merulla J; Catapano CV; Varani G Nucleic Acids Res; 2022 Oct; 50(19):11331-11343. PubMed ID: 36243981 [TBL] [Abstract][Full Text] [Related]
2. A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers. Pisignano G; Napoli S; Magistri M; Mapelli SN; Pastori C; Di Marco S; Civenni G; Albino D; Enriquez C; Allegrini S; Mitra A; D'Ambrosio G; Mello-Grand M; Chiorino G; Garcia-Escudero R; Varani G; Carbone GM; Catapano CV Nat Commun; 2017 May; 8():15622. PubMed ID: 28555645 [TBL] [Abstract][Full Text] [Related]
3. UHRF1 regulates CDH1 via promoter associated non-coding RNAs in prostate cancer cells. Magnani E; Macchi F; Mancini M; Lomazzi V; Cogliati S; Pistore C; Mandruzzato M; Dock-Bregeon AC; Bonapace IM Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):258-270. PubMed ID: 29466696 [TBL] [Abstract][Full Text] [Related]
4. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. Brett A; Pandey S; Fraizer G Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185 [TBL] [Abstract][Full Text] [Related]
5. MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness. Dhar S; Kumar A; Gomez CR; Akhtar I; Hancock JC; Lage JM; Pound CR; Levenson AS FEBS Lett; 2017 Mar; 591(6):924-933. PubMed ID: 28231399 [TBL] [Abstract][Full Text] [Related]
6. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512 [TBL] [Abstract][Full Text] [Related]
7. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer. Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677 [TBL] [Abstract][Full Text] [Related]
8. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter. Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Tryndyak VP; Beland FA; Pogribny IP Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049 [TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Li LC; Chui RM; Sasaki M; Nakajima K; Perinchery G; Au HC; Nojima D; Carroll P; Dahiya R Cancer Res; 2000 Feb; 60(4):873-6. PubMed ID: 10706097 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu J; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H Hum Genet; 2005 Dec; 118(3-4):339-47. PubMed ID: 16189707 [TBL] [Abstract][Full Text] [Related]
13. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Lu MH; Huang CC; Pan MR; Chen HH; Hung WC Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246 [TBL] [Abstract][Full Text] [Related]
14. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence. Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571 [TBL] [Abstract][Full Text] [Related]
15. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. Sossey-Alaoui K; Bialkowska K; Plow EF J Biol Chem; 2009 Nov; 284(48):33019-29. PubMed ID: 19801681 [TBL] [Abstract][Full Text] [Related]
16. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells. Fukagawa A; Ishii H; Miyazawa K; Saitoh M Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. Huang W; Zhang Y; Varambally S; Chinnaiyan AM; Banerjee M; Merajver SD; Kleer CG Am J Pathol; 2008 Apr; 172(4):893-904. PubMed ID: 18321996 [TBL] [Abstract][Full Text] [Related]
18. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer. Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802 [TBL] [Abstract][Full Text] [Related]
19. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631 [TBL] [Abstract][Full Text] [Related]
20. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer. Bure IV; Nemtsova MV; Zaletaev DV Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]